Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/30/1993 | CA1315482C Process for reducing methionine sulfoxide residues |
03/30/1993 | CA1315481C Synthetic polypeptides and antibodies related to epstein-barr virus early antigen-diffuse |
03/30/1993 | CA1315480C Phosphopeptides |
03/30/1993 | CA1315470C Allylic side chain-containing solid phase systems, processes for the preparation thereof and the use thereof in solid phase reactions |
03/30/1993 | CA1315231C Kibdelosporangium aridum sk&f-aad-609 |
03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
03/30/1993 | CA1315224C Biological containment |
03/28/1993 | WO1993006225A1 Method of production of poly-beta-hydroxyalkanoate copolymers |
03/28/1993 | CA2120128A1 Method of production of poly-beta-hydroxyalkanoate copolymers |
03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
03/27/1993 | CA2077888A1 Method for purifying factor viii and preparations obtained |
03/26/1993 | CA2078851A1 Treponema hyodysenteriae vaccine |
03/25/1993 | CA2079027A1 Increased expression of low molecular weight recombinant polypeptides |
03/25/1993 | CA2078721A1 Process for preparing human coagulation factor viii protein complex |
03/25/1993 | CA2078359A1 Protein-dimeric polysaccharide conjugate vaccine |
03/24/1993 | EP0533492A2 A hepatitis B vaccine formulation incorporating a bile acid salt |
03/24/1993 | EP0533408A2 Cosmetics and pharmaceuticals containing extensins |
03/24/1993 | EP0533263A2 A multivalent hepatitis B virus vaccine |
03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
03/24/1993 | EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
03/24/1993 | EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof |
03/24/1993 | EP0532673A1 Immunoassays for anti-hiv-1 antibodies |
03/24/1993 | EP0532650A1 Method of inducing plant defense mechanisms. |
03/24/1993 | EP0532587A1 Methods for trans-destabilization of specific proteins in vivo |
03/24/1993 | EP0532584A1 Dna for diagnosing pneumocystis carinii |
03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
03/24/1993 | EP0346413B1 Potentiation of erythropoiesis |
03/24/1993 | EP0345315B1 Ps2 protein derivative |
03/24/1993 | EP0211894B1 Fsh |
03/24/1993 | EP0180603B1 Rotavirus |
03/24/1993 | EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna |
03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
03/23/1993 | US5196526 Genetic engineering |
03/23/1993 | US5196516 Pseudorabies virus vaccine |
03/23/1993 | US5196514 Method of detecting mycoplasma infection in poultry and compositions therefor |
03/23/1993 | US5196513 Immunodiagnosis |
03/23/1993 | US5196512 For Plasmodium |
03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
03/23/1993 | US5196510 Polypeptides |
03/23/1993 | US5196404 Inhibitors of thrombin |
03/23/1993 | US5196403 Method of inhibiting platelet activation |
03/23/1993 | US5196342 Bacillus thuringiensis P-2 toxin gene |
03/23/1993 | US5196338 Recombinant vectors for Haemophilus influenzae peptides and proteins |
03/23/1993 | US5196334 Urogenital sinus derived growth inhibitory factor |
03/23/1993 | US5196333 DNA sequences involved in neuronal degeneration, multicellular organisms containing same and uses thereof |
03/23/1993 | US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen |
03/23/1993 | US5196323 Antiviral and immunoregulatory activities |
03/23/1993 | US5196321 Methods for in vitro cleavage of ubiquitin fusion proteins |
03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
03/23/1993 | US5196318 Precisely regulated expression of deleterious genes |
03/23/1993 | US5196316 Enzyme and dna coding therefor |
03/23/1993 | US5196308 Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
03/23/1993 | US5196307 Cloned human centromere autoantigen |
03/23/1993 | US5196304 Serine proteinase inhibitor gene from the insect Manduca sexta |
03/23/1993 | US5196303 Cloning of DNA encoding transcription factor S-II and utilization of the DNA |
03/23/1993 | US5196204 Treatment of heart conditions and neurological disorders |
03/23/1993 | US5196196 Use of protease nexin-I in wound dressings |
03/23/1993 | US5196194 Vaccines containing Hepatitis B S-protein |
03/23/1993 | US5196185 Collagen-based wound dressing and method for applying same |
03/23/1993 | CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r' |
03/23/1993 | CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r' |
03/23/1993 | CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r' |
03/23/1993 | CA1314831C Extraction of human interleukin-4 from bacteria |
03/23/1993 | CA1314830C Bar1 secretion signal |
03/23/1993 | CA1314813C Porous solid phases having bioaffinity, a process for preparing porous solid phases having bioaffinity, and their use |
03/23/1993 | CA1314811C Methods for identifying alleles associated with increased risk of diabetes |
03/23/1993 | CA1314810C Heterologous system for the detection of chemically-labeled dna and other biological materials providing a receptor or target moiety thereon |
03/23/1993 | CA1314754C Livestock feeding |
03/21/1993 | WO1993005811A1 A hepatitis b vaccine formulation incorporating a bile acid salt |
03/21/1993 | CA2096650A1 Hepatitis b vaccine formulation incorporating a bile acid salt |
03/21/1993 | CA2078358A1 Multivalent hepatitis b virus vaccine |
03/19/1993 | CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/18/1993 | WO1993005172A1 Morphogenic protein screening method |
03/18/1993 | WO1993005169A1 Hybrid cytokines |
03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
03/18/1993 | WO1993005164A1 Callus-specific promoters |
03/18/1993 | WO1993005156A1 Streptolysin o derivatives |
03/18/1993 | WO1993005155A1 Streptolysin o variants |
03/18/1993 | WO1993005153A1 Biocidal proteins |
03/18/1993 | WO1993005151A1 Cloned human cenp-c antigen |
03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
03/18/1993 | WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer |
03/18/1993 | WO1993005147A1 Defective interfering hiv particles with chimeric cd4-env |
03/18/1993 | WO1993005073A1 ANGIOTENSIN IIcAMP/VASOPRESSINV2 RECEPTORS AND RELATED MOLECULES AND METHODS |
03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
03/18/1993 | WO1993005067A1 Topical fibrinogen complex |
03/18/1993 | WO1993005066A1 Heat labile toxin of bordetella |
03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
03/18/1993 | WO1993005056A1 A helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc and mad |
03/18/1993 | WO1993005026A1 Peptide isoters containing a heterocycle as h.i.v. inhibitors |
03/18/1993 | WO1993004702A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
03/18/1993 | WO1993004700A1 Vα12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
03/18/1993 | WO1993004699A1 Therapeutic method for iddm |
03/18/1993 | WO1993004697A1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
03/18/1993 | WO1993004696A1 Method and composition for killing malaria parasites |